Dr. Arnab Basu, MD

Dr. Basu practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Basu's NPI, 1669734083, was assigned on June 12, 2012. Dr. Basu graduated from Medical College and Hospital Kolkata in 2007. Dr. Basu's Alabama license number on file is 38568.

Dr. Basu's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Basu's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. Dr. Basu is also affiliated with UAB Hospital. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Basu to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Basu practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Basu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Basu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Basu's licenses on file in 3 states: Alabama, California and Ohio.

Dmand AI lists breast cancer, colorectal cancer, lung cancer and prostate cancer among the conditions Dr. Basu treats.

CMS data shows 599 Medicare services from Dr. Basu across 4 procedure codes in 2024, for 193 Medicare patients. Medicare paid $34,252 for them.

CMS counts 193 Medicare patients who saw Dr. Basu in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Basu's median patient age at 69, with 26% women.

In 2024, Dr. Basu wrote 3,161 Medicare Part D claims for 236 patients. 59% of them were for generic drugs. CMS names the drug for 2,895 of them, across 52 drugs with 11 or more claims each, at $15,893,423 in total drug cost. In 2023, CMS named 2,673 claims across 44 drugs.

Dr. Basu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Basu as offering telehealth.

Dmand AI links 69 papers to Dr. Basu, published from 2006 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Bacterial Proteins. Dr. Basu has published most often in J Virol. Dr. Basu's most frequent co-authors are Arpita Desai, MD, Vadim S. Koshkin, MD and Mehmet Asim Bilen, MD.

Dmand AI links Dr. Basu to 3 clinical trials, 3 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Renal Cell, Ureteral Neoplasms and Kidney Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 364 general payments to Dr. Basu from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 33% of the total. Eisai Inc. paid the most, $322,188. It also lists 9 research payments totaling $2,455 in 2022.

Dmand AI lists 2 awards for Dr. Basu, most recently Winner, Resident Research Competition in 2015.

Dr. Basu graduated from Medical College and Hospital Kolkata in 2007. Dr. Basu is a member of ACP and ASCO.

Dr. Basu is in network with 13 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.